Financials

  • Market Capitalization 4.87 B
  • Employee 258
  • Founded 2017
  • CEO N/A
  • Website www.dyne-tx.com
  • Headquarter Delaware, United States
  • FIGI BBG00NSGPJD0
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1272
LGND
Ligand Pharmaceuticals Incorporated - Common Stock
284.52 USD-1.16%-1.24%-3.43%+52.05%5.67 B USD
1341
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
29.73 USD+0.51%+2.24%+13.82%+13.52%5.12 B USD
1386
EWTX
Edgewise Therapeutics, Inc. - Common Stock
44.19 USD-0.43%+1.49%+9.54%+190.15%4.80 B USD
1423
CELC
Celcuity Inc. - Common Stock
93.24 USD-1.94%+2.02%+12.65%+71.08%4.56 B USD

Frequently asked questions about Dyne Therapeutics, Inc. Common Stock

What is the Dyne Therapeutics, Inc. Common Stock stock price today?

The current price of Dyne Therapeutics, Inc. Common Stock (DYN) is 26.09. Over the past 24 hours, the stock has changed by -1.02%. Follow the DYN chart for real-time price dynamics.

What is the stock ticker of Dyne Therapeutics, Inc. Common Stock?

Dyne Therapeutics, Inc. Common Stock trades under the ticker DYN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Dyne Therapeutics, Inc. Common Stock stock going up?

DYN has changed by -0.50% over the last week, +0.50% over the last month, and +11.45% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Dyne Therapeutics, Inc. Common Stock?

Dyne Therapeutics, Inc. Common Stock currently has a market capitalization of 4.87 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Dyne Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Dyne Therapeutics, Inc. Common Stock reported earnings of -1.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Dyne Therapeutics, Inc. Common Stock net income for the last quarter?

Dyne Therapeutics, Inc. Common Stock reported net income of -178.56 M for the last quarter. The previous quarter showed -120.85 M, which means net income changed by -47.75%.

How many employees does Dyne Therapeutics, Inc. Common Stock have?

As of the latest available data, Dyne Therapeutics, Inc. Common Stock has 258 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Dyne Therapeutics, Inc. Common Stock stock?

You can buy Dyne Therapeutics, Inc. Common Stock (DYN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Dyne Therapeutics, Inc. Common Stock stock?

Investing in Dyne Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DYN chart and related analysis on metatrader.com as part of your research.

News